Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tharimmune Inc (THAR)

Tharimmune Inc (THAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 83,758
  • Shares Outstanding, K 35,045
  • Annual Sales, $ 0 K
  • Annual Income, $ -12,200 K
  • EBIT $ -10 M
  • EBITDA $ -10 M
  • 60-Month Beta 1.43
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.05

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.18 +9.61%
on 11/20/25
5.27 -54.65%
on 11/07/25
-1.60 (-40.10%)
since 11/05/25
3-Month
2.18 +9.61%
on 11/20/25
6.89 -65.31%
on 11/03/25
-1.29 (-35.05%)
since 09/05/25
52-Week
0.95 +151.05%
on 04/07/25
9.08 -73.68%
on 08/25/25
+0.36 (+17.73%)
since 12/05/24

Most Recent Stories

More News
Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression from Fentanyl and Ultrapotent Opioids

RED BANK, N.J. , Nov. 13, 2025 /PRNewswire/ -- Tharimmune, Inc. (Nasdaq: THAR) ("Tharimmune" or the "Company"), a digital asset treasury company with a clinical-stage biotechnology function,...

THAR : 2.39 (-3.24%)
Tharimmune, Inc. Closes $545 Million Private Placement to Establish Canton Coin Treasury Strategy

Led by DRW and Liberty City Ventures, Transaction Cements Tharimmune as First Public Company to Deliver Canton-Aligned DAT Strategy

THAR : 2.39 (-3.24%)
Tharimmune, Inc. Announces Private Placement of Approximately $540 Million Led by DRW and Liberty City Ventures to Establish Canton Coin Treasury Strategy

NEW YORK , Nov. 3, 2025 /PRNewswire/ -- Tharimmune, Inc. (NASDAQ: THAR) ("Tharimmune" or the "Company") today announced that it has entered into subscription agreements with certain institutional...

THAR : 2.39 (-3.24%)
Tharimmune Increases Authorized Shares to 1 Billion

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Tharimmune...

THAR : 2.39 (-3.24%)
Tharimmune Stockholders Approve Key Strategic Proposals

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest...

THAR : 2.39 (-3.24%)
Tharimmune Amends Warrants Agreement to Boost Liquidity

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Tharimmune...

THAR : 2.39 (-3.24%)
Micro-Cap Biotech Firm Soars 200% on Fentanyl, Ultrapotent Opioids Breakthrough

Tharimmune (NASDAQ: THAR) stunned Wall Street on Wednesday, with its stock surging more than 200% after announcing positive simulation results for TH104, a novel opioid countermeasure, and securing an...

THAR : 2.39 (-3.24%)
Tharimmune Reports Pharmacokinetic Simulation Results for TH104 as Prophylaxis Against Respiratory Depression from Fentanyl and Ultrapotent Opioids, Highlighting Potential Superiority Over Existing Treatments

RED BANK, NJ / ACCESS Newswire / August 20, 2025 / Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company dedicated to developing innovative therapeutic...

THAR : 2.39 (-3.24%)
Tharimmune Secures Key Global Patents for TH-104, Laying Foundation for Broader Indications Following Initial Development as a National Security Medical Countermeasure Against Weaponized Fentanyl

RED BANK, NEW JERSEY / ACCESS Newswire / August 13, 2025 / Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company dedicated to developing innovative therapeutic...

THAR : 2.39 (-3.24%)
Nancy Davis, Visionary Philanthropist and Founder of Race to Erase MS and Cure Addiction Now Appointed to the Tharimmune Board of Directors

RED BANK, NJ / ACCESS Newswire / August 5, 2025 / Tharimmune, Inc. (NASDAQ:THAR), ("Tharimmune" or the "Company), a clinical-stage biotechnology company dedicated to developing innovative therapeutic candidates...

THAR : 2.39 (-3.24%)

Business Summary

Tharimmune Inc. is a biotechnology company. It involved in developing a portfolio of therapeutic candidates for rare immune, inflammatory and oncologic diseases. Tharimmune Inc., formerly known as Hillstream BioPharma Inc., is based in BRIDGEWATER, NJ.

See More

Key Turning Points

3rd Resistance Point 2.57
2nd Resistance Point 2.52
1st Resistance Point 2.46
Last Price 2.39
1st Support Level 2.34
2nd Support Level 2.29
3rd Support Level 2.23

See More

52-Week High 9.08
Fibonacci 61.8% 5.98
Fibonacci 50% 5.02
Fibonacci 38.2% 4.06
Last Price 2.39
52-Week Low 0.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar